Boston Scientific Posts Loss
90989
The medical device maker reported a third-quarter loss of $272 million on charges related to acquisitions and asset sales, as the companyâs top-selling stent continued to slump.
70317
MedImmune Inc. reported a third-quarter loss yesterday, despite $61 million in sales of its lead product, Synagis, a 25 percent increase over the same period a year ago.
35763
D. R. Horton posted a loss of $128.8 million, or 41 cents a share, for the first quarter ended Dec. 31, in contrast to a year-earlier profit of $109.7 million, or 35 cents a share.
715189
Boston Scientific said Thursday that three of its subsidiaries had agreed to pay $16.75 million and extend the warranty on some of its heart devices as part of a settlement with state attorneys general.
742004
Boston Scientific reported weaker quarterly earnings on higher expenses from its acquisition of the Guidant Corporation.
665807
Chip maker Advanced Micro Devices  Inc. AMD.N on Tuesday reported a quarterly loss from a  year-earlier profit following a reduced forecast it gave last  week.
115320
Shares of Boston Scientific Corp. (BSX.N: Quote, Profile, Research) slid more than 3 percent in premarket trading on Wednesday after reporting that sales of its Taxus stent slowed
599091
Advanced Micro Devices Inc , the world's second-largest maker of computer microprocessors, on Thursday posted a wider quarterly net loss due to a $1.68 billion charge related to its purchase of graphics chipmaker ATI.
679156
Boston Scientific Corp.  said on Friday it will pay $195 million to settle numerous legal claims related to the recall of implantable heart defibrillators made by Guidant Corp., which it acquired last year.
139261
Boston Scientific Corp. said yesterday it has won back the market share that its flagship cardiac stent system held before three safety recalls reduced doctors&#39; orders of the product.
524340
NEW YORK, September 1 (New Ratings) - Boston Scientificâs (BSX.NYS) share price rose more than 6% on the news of market share regains by Taxus, the company&#39;s drug-coated stent.
667257
The Vienna, Va.-based developer of treatments for cancer and infectious diseases said its loss fell to 1 cent per share versus 3 cents per share in the same quarter a year earlier, according to an SEC filing.
153744
The chip maker reported a net loss of $396 million, larger than Wall Street expected, but sales were up 23 percent on strong personal-computer demand.
43609
Boston Scientific Corp.  posted lower-than-expected quarterly profit on Friday as sales of its flagship drug-eluting heart stents fell by 32 percent.
586414
Boston Scientific Corp. said Wednesday it expects overall third-quarter sales will miss analyst expectations as preliminary August sales of its Taxus heart device, which was involved in
156096
Boston Scientific Corp. (BSX.N: Quote, Profile, Research) , whose Taxus heart device has been involved in a major recall, said on Wednesday preliminary August sales of the device slowed
477052
Advanced Micro Devices  (AMD), the world's second-largest maker of computer microprocessors, posted a wider quarterly loss on Thursday due to a $1.68 billion charge from its purchase of graphics chipmaker ATI.